top Dutasteride CAS NO.164656-23-9

FOB Price:: USD 1.00-1.00 /Gram Get Latest Price

Min.Order Quantity:: 1 Gram

Purity:: 99% min

Port:: China main port

Payment Terms:: L/C,T/T,

Add to Inquiry Cart

Product Details

Keywords

Dutasteride
high purity Dutasteride
factory supply Dutasteride

Quick Details

ProName: top Dutasteride
CasNo: 164656-23-9
Molecular Formula: C27H30F6N2O2
Appearance: Crystalline
Application: Pharmaceutical intermediates
DeliveryTime: With about 7-10 days after receipt the...
PackAge: as you requested
Port: China main port
ProductionCapacity: 10 Kilogram/Day
Purity: 99% min
Storage: Room temperature
Transportation: by courier
LimitNum: 1 Gram
Transportation: by courier

Superiority

our company was built in 2009 with an iso certificate.in the past 5 years, we have grown up as a famous fine chemicals supplier in china and we had established stable business relationships with samsung,lg,merck,thermo fisher scientific and so on.our main business covers the fields below:

1.noble metal catalysts (pt.pd...)

2.organic phosphine ligands (tert-butyl-phosphine.cyclohexyl-phosphine...)

3.oled intermediates (fluorene,carbazole,boric acid...)

4.customs synthesis

our advantage:

1. higest quality and good package

2.fast delivery

3.better payment term

4.fast response to customer within 6 hours

5.good business credit in europe ,us ,japan ,korea

anyway ,if you need any chemicals from china ,henan tianfu can help you

Details

product name:	dutasteride
synonyms:	(1s,2r,7r,10s,11s,14s,15s)-n-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide;(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide;(5α,17β)-;(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide-13c6;6β-hydroxy dutasteride;4-azaandrost-1-ene-17-carboxamide, n-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5a,17b)-;avolve;dutasteride api
cas:	164656-23-9
mf:	c27h30f6n2o2
mw:	528.53
einecs:
product categories:	hormone drugs;api;miscellaneous biochemicals;all inhibitors;inhibitors;intermediates & fine chemicals;pharmaceuticals;steroids;steroid and hormone
mol file:	164656-23-9.mol

dutasteride chemical properties

melting point	242-250°c
storage temp.	-20°c freezer
solubility	dmso: soluble2mg/ml, clear
color	white to beige
inchikey	jwjotenamicljg-qwbycmeysa-n

safety information

msds information

dutasteride usage and synthesis

indications and usage	dutasteride is the first and only double 5α reductase inhibitor used to treat prostatic hyperplasia, and it is mainly used clinically to treat prostate enlargement, male-pattern hair loss, seborrheic hair loss, and hereditary hair loss.
mechanisms of action	the human body contains type i and type ii 5α reductase, with type ii found mainly in the prostate, and type i found mainly in the liver and skin. 5α reductase is the main cause for continuous benign prostate enlargement; it promotes the transformation of testosterone in patients’ prostate into the more active dihydrotestosterone, thus causing prostate cells to enlarge and the prostate to swell. dutasteride can inhibit both type i and ii 5α reductase at the same time. this type of simultaneous inhibiting mechanism can rapidly and continuously reduce prostate size, dramatically improve urination, and reduce the risk fo acute urinary retention and its related prostate surgeries.
clinical research	the american fda approved a 2-year multicenter randomized double-blind control clinical trial – the first long term clinical assessment of the combined usage of dutasteride and α receptor blockers. included subjects were male patients with moderate to severe prostate enlargement (ages greater than or equal to 50, prostate volume (pv) ≥30 cc, serum prostate specific antigen (psa) levels 1.5-10ng/ml, 5ml/sec < maximum urinary flow (qmax) ≤15ml/sec, minimum urination ≥ 125ml, international prostate symptom score (ipss) ≥ 12). patients were first given a placebo for 4 weeks and then were randomly given either 0.5mg/day of dutasteride and 0.4mg/day of tamsulosin, only 0.5mg/day of dutasteride, or only 0.4mg/day of tamsulosin. results showed: after 12-24 months, the combined usage of dutasteride with tamsulosin had better curative effects than did individual usage.
side effects	erectile dysfunction, reduced libido, breast diseases (including enlarged or swelling breasts), ejaculation difficulties and dizziness.
contradictions	not to be used by women and children.
chemical properties	white crystalline solid
uses	used in the treatment of benign prostatic hyperplasia. dual inhibitor of 5a-reductase isoenzymes type 1 and 2; structurally related to finasteride.
uses	used in the treatment of benign prostatic hyperplasia. dual inhibitor of 5α-reductase isoenzymes type 1 and 2; structurally related to finasteride.
uses	antihypertensive, ace inhiibitor
uses	dutasteride is a dual inhibitor of 5α-reductase isoenzymes type 1 and 2; structurally related to finasteride (f342000). dutasteride is used in the treatment of benign prostatic hyperplasia.
definition	chebi: finasteride in which the tert-butyl group is replaced by a 2,5-bis(trifluoromethyl)phenyl group. a synthetic 4-azasteroid, dutasteride is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5alpha-reductase an intracellular enzyme that converts testosterone to 5alpha-dihydrotestosterone. dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.